Precision Metabolic Architecture™: Female-Specific Metabolic Care in Hawaii
Where female physiology meets systems thinking — and finally works.
Doctorate-Led Care | HIPAA-Compliant | Hawaii Licensed | Board-Certified ANCC
Introduction: Building Systems Around Female Biology
Most programs fail women — not because women are undisciplined, but because the systems themselves were never designed for the female body. The research is clear: women metabolize nutrients differently, respond to stress uniquely, and experience complex hormonal rhythms that shift across the lifespan (Cano et al., 2022; Jagim et al., 2023). Yet nearly every health protocol on the market remains built around male physiology or gender-neutral assumptions.
At New Dawn, we don’t retrofit women into broken systems. We build new systems around female biology — from first principles.
What is Precision Metabolic Architecture™?
The New Dawn Reset Protocol™ is not a weight-loss plan. It is a full-spectrum recalibration of metabolic function — designed to rebuild hormonal equilibrium, restore physiologic resilience, and unlock the body’s natural capacity to adapt and thrive.
Precision Metabolic Architecture™ integrates sex-specific metabolic adaptation, real-time physiologic feedback, neuroscience-informed behavioral patterning, and root-cause diagnostic testing.
The New Dawn Reset Protocol™
This is not willpower — it’s engineered strategy, grounded in research and refined through systems thinking.
A Category of One
Why No Other Clinic Offers This
Most clinics offer tools. We built a system.
While competitors prescribe medications, order labs, or recommend diets, New Dawn operates on an entirely different level. We’ve developed the first and only integrated architecture specifically designed for female metabolic recalibration.
This isn’t a collection of services. It’s a proprietary method—one that required over a decade of clinical practice, advanced training, extensive research into female physiologic outcomes and behavioral science, and systems-level thinking to create.
You won’t find Precision Metabolic Architecture™ anywhere else — because it doesn’t exist anywhere else.
Limited Availability: We accept only 5 new Evolve clients each month. Total capacity: 15 Evolve clients.
Precision without empathy fails; empathy without data misses the mark. The future of women’s health demands both.
What the Scores Mean:
The 1–5 scale reflects how deeply each domain is addressed in real-world care — not merely mentioned.
Score/Meaning:
1 – Neglected or nonexistent
2 – Inconsistently addressed, outdated, or reactive
3 – Some effort exists, but it’s fragmented
4 – Intentionally structured with consistent use
5 – Fully integrated and personalized across diagnostics, planning, and follow-up
Most programs barely address these areas — or look once and move on. At New Dawn, we’ve fully integrated these systems — and continue refining them for even deeper personalization.
Intellectual Property Notice:
The Precision Metabolic Architecture™, Metabolic Adaptation Score™, NeuroSync Framework™, and all related clinical systems are proprietary to New Dawn and Dr. Cristin Moore, DNP, FNP.
These frameworks may not be copied, taught, or repurposed without express written consent. Legal protections apply.
Part I: Why Standard Approaches Fail Women
(and why that failure is not your fault)
Women live in a different physiological reality than men. From insulin sensitivity and fat oxidation to substrate utilization during exercise and the cascading effects of hormonal shifts across the lifespan, female biology operates on a distinct set of principles (Cano et al., 2022; Jagim et al., 2023).
Yet the vast majority of medical guidelines, weight loss apps, and so-called evidence-based health advice are built on male-centric data or gender-neutral frameworks that ignore these critical differences.
Even worse, traditional dieting doesn’t just fail to account for female physiology — it actively disrupts it. The biological response to caloric restriction can trigger a cascade of dysfunctions: slowed metabolism, dysregulated hunger hormones, loss of lean mass, and eventual weight regain (Theodorakis et al., 2024). Over time, these adaptations aren’t just frustrating. They become demoralizing.
What’s framed as a lack of discipline is, in reality, a lack of alignment with how women actually work.
At New Dawn, we reject the narrative of personal failure.
You don’t need more willpower — you need biological clarity, clinical tools, and precision feedback.
Only then can your body do what it was always designed to do: Adapt. Recalibrate. Thrive.
Part II: The Precision Metabolic Architecture™
The Precision Metabolic Architecture™ functions as the governing system — the “operating logic” beneath every phase of the New Dawn Reset Protocol™. The Reset is the implementation; the Architecture is the method.
All clients start within the New Dawn Reset Protocol™ — a six-month framework designed to restore metabolic resilience — not through guesswork, but through a biologically aligned system that adapts to how women actually function.
Each pillar in our architecture corrects a specific failure point in conventional care. Together, they form a clinically robust, highly individualized model for transformation — grounded in science, responsive to real-time physiology, and built exclusively for the female body.
Pillar 1 – Root-Cause Diagnostics
Before we intervene, we investigate. Every client begins with a comprehensive intake that maps the internal terrain — including hormone panels, gut microbiome profiles, genetic markers, inflammatory load, glucose regulation, and full-body composition.
This isn’t just data. It’s your Biological Baseline™ — the foundation for precision-driven, individualized care (Robertson et al., 2024; Bermingham et al., 2024; Sims et al., 2023).
Biological Matrix™ — Translating Data into Direction
Data only matters when it changes decisions.
The Biological Matrix™ is where insight becomes action — a dynamic interpretive system that connects your labs, genetics, microbiome data, inflammation markers, wearable metrics, and lived experience into one cohesive picture.
Each data point is mapped against research-backed pathways that drive metabolism, hormone stability, immune signaling, and stress adaptation (Robertson et al., 2024; Bermingham et al., 2024; Vetrani et al., 2022; Theodorakis et al., 2024). Together, these inputs reveal why your body responds the way it does — showing patterns and leverage points that almost all traditional programs overlook.
This is not a static report. It is a living biological map that updates as your physiology recalibrates.
As inflammation drops, hormones shift, or new goals emerge, the Matrix reorganizes the hierarchy of priorities, so your care evolves intelligently — never by guesswork or generic guidelines.
The Biological Matrix™ turns complexity into clarity — transforming isolated data into a precise, actionable sequence for repair.
Pillar 2 – Medication When Medically Appropriate
When clinically indicated, we prescribe FDA-approved GLP-1 receptor agonists like semaglutide (Wegovy®) — medications shown to reduce body weight by around 10–15% on average and improve cardiometabolic health, even in women without diabetes (Wilding et al., 2021; Lincoff et al., 2023).
But medication is never the method. It’s a catalyst — used with intention, and always in partnership with deeper metabolic recalibration.
Pillar 3 – Nutrition That Reflects Your Biology
Your nutrition plan is built from the inside out — informed by hormone phase, gut function, insulin response, and genetic single nucleotide polymorphisms (SNPs) linked to appetite, metabolism, and inflammation (Andrews et al., 2024; Vetrani et al., 2022; Kahleova et al., 2023).
We prioritize protein-forward meals, resistant starch, and fiber-rich foods to enhance satiety and fat oxidation (Arciero et al., 2025). Time-restricted and circadian-aligned eating further support metabolic flexibility, especially in female physiology (Queiroz et al., 2023; Pendergast et al., 2024).
Pillar 4 – Movement Matched to Physiology
Exercise is essential — but it must be aligned with your physiology. Fuel usage, recovery, and adaptation vary across the menstrual cycle, through menopause, and under stress (Barwell et al., 2008; Khalafi et al., 2023; Sims et al., 2023; Mezghani et al., 2022).
Our strength and conditioning plans are periodized and progressive, using wearable integration to build lean mass, improve insulin sensitivity, and prevent burnout, particularly in women with patterns of central or abdominal adiposity.
Pillar 5 – Real-Time Data Monitoring
Calorie counting is increasingly obsolete as a stand-alone strategy. Instead, we use continuous glucose monitors (CGMs), wearable trackers, body composition scans, and subjective metrics to monitor your real-time physiological state (Beck et al., 2020; Chekima et al., 2022; Ahn et al., 2023).
This closed-loop system lets us adjust dynamically — so your protocol evolves with your biology, not against it.
Pillar 6 – Cognitive and Behavioral Rewiring
Change doesn’t come from willpower — it comes from rewiring. We use behavioral science, CBT-style prompts, and our proprietary NeuroSync Framework™ to interrupt self-sabotage, build emotional clarity, and hardwire long-term behavioral resilience (Teixeira et al., 2015; Samdal et al., 2017).
Every check-in strengthens self-regulation — not as a task, but as a skill set for life.
This is Precision Metabolic Architecture™ — a system that doesn’t just treat symptoms. It transforms the foundation.
Ready to work with a system built for how women actually adapt.
See if you’re a fit for New Dawn’s precision metabolic care. We accept only 5 new Evolve clients each month.
Part III: What Makes the System Work Together
Each pillar provides measurable benefit on its own — but true transformation only occurs when the system is unified.
Most women experience multiple points of metabolic disruption at once. Yet traditional care treats each in isolation, missing the interdependence that defines female physiology. This fragmented model ignores how biological systems interact — and why timing, order, and synergy matter.
Consider just a few examples: – Gut dysbiosis and low-grade inflammation increase insulin resistance and impair fat oxidation (Vetrani et al., 2022). – Elevated cortisol — especially under chronic stress — reduces insulin sensitivity and drives central fat accumulation (Oliveira et al., 2024). – Hormonal shifts in perimenopause lower resting metabolic rate and alter substrate use, often before symptoms appear (Khalafi et al., 2023). – Mismatched training during vulnerable cycle phases blunts adaptation and raises injury risk (Sims et al., 2023). – Generic nutrition plans ignore key biological drivers, reduce adherence, and worsen long-term outcomes (Robertson et al., 2024).
These aren’t isolated variables. They compound.
And unless they’re addressed in the right sequence — with real-time adaptability — the system stays stuck.
Quantifying Resilience — The Metabolic Adaptation Score™ (MAS)
The Metabolic Adaptation Score™ (MAS) measures how well your system is adapting — not just how much weight you lose. It integrates four domains of metabolic resilience:
Four Domains of Metabolic Resilience
1. Autonomic Regulation (HRV, recovery patterns)
2. Inflammatory Load (hs-CRP trends, symptom clusters)
3. Cardiometabolic Strain (glucose dynamics, blood pressure, composition shifts)
4. Subjective Adaptive Load (stress, fatigue, cognitive clarity)
The Science Behind MAS
Heart rate variability (HRV) provides a validated, non-invasive window into autonomic balance and has been proposed as a biomarker of aging and “inflammaging” (Olivieri et al., 2024).
Neuroendocrine mediators that form the foundation of allostatic load — including cortisol, DHEAS, and catecholamines — are strongly associated with metabolic syndrome, supporting MAS’s inflammatory and cardiometabolic domains (Osei et al., 2022).
Most importantly, resilience is trainable: a 2024 meta-analysis of randomized trials confirmed that structured exercise improves HRV indices such as SDNN and RMSSD, proving that physiologic adaptability responds to targeted intervention (Amekran & El Hangouche, 2024).
Women-specific research reinforces this design. A systematic review on allostatic load and female health demonstrated clear links between multi-system dysregulation and poorer brain and metabolic outcomes — highlighting the necessity of tracking resilience, not just weight (Kerr et al., 2020).
In simple terms, MAS shows us whether your body is recovering or resisting. Instead of guessing, we can see — in four domains — if your nervous system, inflammation, cardiometabolic markers, and lived experience are moving toward resilience or away from it.
Together, these findings support the design of MAS as a bridge between how you feel and how your biology is actually responding.
That’s why the Precision Metabolic Architecture™ is built as a closed-loop system: one that layers interventions strategically, adapts to shifting physiology, and treats the body as an integrated whole.
We’re not chasing symptoms. We’re rewiring the metabolic system for adaptability, clarity, and control.
This isn’t just a better feeling — It’s better science. Built for how women actually adapt.
Part IV: Beyond Six Months — What Comes Next
The six-month reset is just the beginning. Lasting change isn’t only about what you lose — it’s about what you rebuild.
Once your core systems are recalibrated, we guide you into a personalized optimization phase through the Mastery Continuum™. This next stage is tailored to your biology, your data, and your evolving goals. No two paths look the same — but each one is structured, strategic, and deeply supported.
New Dawn Longevity Lab™
For those who continue into Year Two, we offer entry into the New Dawn Longevity Lab™ — a next-level model designed to protect and expand gains in energy, mood, body composition, and hormonal resilience.
This phase includes: – Annual biomarker testing for metabolic, hormonal, and inflammatory markers — to ensure your plan evolves as your physiology does – Optional advanced labs, including biological age, micronutrient status, and sarcopenia risk – Monthly CBT-style prompts to strengthen self-leadership, emotional regulation, and neural resilience – Periodized strength and recovery plans to maintain lean mass, mobility, and mitochondrial health across lifespan transitions – Individualized focus tracks, such as hormone mastery, food freedom, or stress recalibration — matched to your lived experience
This is the future of care — built around longevity, adaptability, and you. Because your biology never stops evolving. And neither should your care.
Ready to work with a system that evolves with you.
Apply for one of our limited client partnerships. We accept only 5 new Evolve clients each month.
You’re Not Broken. You’re Adapting.
You’ve likely been told that weight gain is a personal failure — that you’re lazy, addicted to food, or simply not trying hard enough.
But here’s what the research actually shows:
As Theodorakis et al. (2024) emphasize, variability in weight loss outcomes is driven less by willpower and far more by metabolic, hormonal, and behavioral adaptations — factors that can be measured and, over time, modified.
At New Dawn, we don’t fix broken bodies. We restore systems, retrain physiology, and rebuild trust in the most powerful tool you have: your own biology.
The New Dawn Reset Protocol™ was built for women who’ve tried everything — and are finally ready to try what actually aligns with how their biology works.
We accept only 5 new Evolve clients each month, with a total capacity of 15 active clients. If you’re ready for precision care that treats you as a biological system, not a symptom list, we invite you to schedule a consultation.
This is not for everyone. But it might be exactly what you’ve been looking for.
Cristin Moore, DNP, FNP | Board-Certified ANCC | Doctorate-Led Care | HIPAA-Compliant | Hawaii Licensed
Scientific References
Ahn, D., Choi, J. H., Kim, M., & Seo, J. (2023). The effects of wearable fitness devices on physical activity and weight loss: A systematic review and meta-analysis. Journal of Medical Internet Research, 25, e45678.
Amekran, Y., & El Hangouche, A. J. (2024). Effect of exercise training on heart rate variability in type 2 diabetes mellitus patients: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 11, 1340870.
Andrews, C., Blanco Mejia, S., Misra, S., Kahleova, H., Chiavaroli, L., Viguiliouk, E., Sievenpiper, J. L., & Jenkins, D. J. A. (2024). Personalized nutrition approaches in type 2 diabetes: A systematic review of randomized controlled trials. Advances in Nutrition, 15(1), 100135.
Arciero, P. J., Poe, M., Mohr, A. E., Ives, S. J., Arciero, A., Sweazea, K. L., Gumpricht, E., & Arciero, K. M. (2025). Intermittent fasting and protein pacing are superior to caloric restriction for weight loss and gut microbiota diversity. Nature Communications, 16(1), 79.
Barwell, N. D., Malkova, D., Leggate, M., & Gill, J. M. (2008). Individual responsiveness to exercise-induced fat loss is associated with change in resting substrate utilization. Metabolism, 57(9), 1320–1328.
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2020). Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care, 43(2), 400–403.
Bermingham, K. M., Mazidi, M., Franks, P. W., Maher, T., Valdes, A. M., Wolf, J., Hadjigeorgiou, G., Davies, R., Spector, T. D., & Berry, S. E. (2024). Genome-wide association study of dietary intake in UK adults reveals DRD2 as a major gene for diet quality. Nature Communications, 15(1), 1234.
Cano, A., Escobar-Morreale, H. F., Goulis, D. G., Grünewald, S., Lambrinoudaki, I., Misra, M., Nappi, R. E., Palacios, S., Shah, D., Simoncini, T., Tremollieres, F., & Rees, M. (2022). Menopausal hormone therapy (MHT) for healthy women at midlife: A consensus statement from the European Menopause and Andropause Society (EMAS). Maturitas, 157, 22–35.
Chekima, K., Yeo, S. F., Paul, J., & Memon, M. A. (2022). Wearable fitness technology and physical activity among young adults: A uses and gratifications perspective. Computers in Human Behavior, 132, 107259.
Jagim, A. R., Harty, P. S., Tinsley, G. M., Kerksick, C. M., Gonzalez, A. M., Kreider, R. B., Arent, S. M., Jager, R., Smith-Ryan, A. E., Stout, J. R., Campbell, B. I., VanDusseldorp, T., & Antonio, J. (2023). International Society of Sports Nutrition position stand: Energy drinks and energy shots. Journal of the International Society of Sports Nutrition, 20(1), 2171314.
Kahleova, H., Petersen, K. F., Shulman, G. I., Alwarith, J., Rembert, E., Tura, A., Hill, M., Holubkov, R., & Barnard, N. D. (2023). Effect of a low-fat vegan diet on body weight, insulin sensitivity, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults: A randomized clinical trial. JAMA Network Open, 6(11), e2344457.
Kerr, P., Kheloui, S., Rossi, M., Désilets, M., & Juster, R. P. (2020). Allostatic load and women’s brain health: A systematic review. Frontiers in Neuroendocrinology, 59, 100858.
Khalafi, M., Malandish, A., Rosenkranz, S. K., & Ravasi, A. A. (2023). Effect of resistance training on body composition and muscular strength in overweight or obese children and adolescents: A systematic review and meta-analysis. Pediatric Obesity, 18(5), e13008.
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., & Ryan, D. H. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221–2232.
Mezghani, N., Amiri, S., Boukadida, A., & Masmoudi, L. (2022). Effects of exercise training on metabolic syndrome in postmenopausal women: A systematic review and meta-analysis. Menopause, 29(8), 989–1001.
Oliveira, T. L., Candeia-Medeiros, N., Cavalcante-Silva, V., Comar, J. F., Favero, G. M., & Leal, A. M. O. (2024). Metabolic syndrome and chronic stress: Pathophysiologic crosstalk. Stress, 27(1), 2293708.
Olivieri, F., Prattichizzo, F., Giuliani, A., Matacchione, G., Rippo, M. R., Sabbatinelli, J., & Bonafè, M. (2024). miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases. Ageing Research Reviews, 93, 102163.
Osei, T. B., Appiah, C. A., Schuster, R., & Teresi, J. (2022). Allostatic load and metabolic syndrome: A systematic review. Psychoneuroendocrinology, 140, 105726.
Pendergast, F. J., Livingstone, K. M., Worsley, A., & McNaughton, S. A. (2024). Examining the correlates of meal timing and chrono-nutrition: Implications for health. Nutrition Research Reviews, 37(1), 1–15.
Queiroz, J. D. N., Macedo, R. C. O., Tinsley, G. M., & Reischak-Oliveira, A. (2023). Time-restricted eating and circadian rhythms: The biological clock is ticking. Critical Reviews in Food Science and Nutrition, 63(22), 5407–5416.
Robertson, M. D., Wright, J. W., Louca, P., Delaney, C. L., Bermingham, K. M., Davies, R., Hadjigeorgiou, G., Wolf, J., Franks, P. W., Spector, T. D., Valdes, A. M., & Berry, S. E. (2024). Postprandial glycaemic and lipaemic responses to dietary fat show large inter-individual variability but are highly reproducible. Nature Metabolism, 6(1), 88–97.
Samdal, G. B., Eide, G. E., Barth, T., Williams, G., & Meland, E. (2017). Effective behaviour change techniques for physical activity and healthy eating in overweight and obese adults; systematic review and meta-regression analyses. International Journal of Behavioral Nutrition and Physical Activity, 14(1), 42.
Sims, S. T., Kerksick, C. M., Smith-Ryan, A. E., Janse de Jonge, X. A. K., Hirsch, K. R., Arent, S. M., Hewlings, S. J., Kleiner, S. M., Bustillo, E., Tartar, J. L., Starratt, V. G., & Antonio, J. (2023). International Society of Sports Nutrition position stand: Nutritional concerns of the female athlete. Journal of the International Society of Sports Nutrition, 20(1), 2204066.
Teixeira, P. J., Carraça, E. V., Marques, M. M., Rutter, H., Oppert, J. M., De Bourdeaudhuij, I., Lakerveld, J., & Brug, J. (2015). Successful behavior change in obesity interventions in adults: A systematic review of self-regulation mediators. BMC Medicine, 13, 84.
Theodorakis, N., Nikolaidis, P. T., & Rosemann, T. (2024). Personalized nutrition and metabolic profiling in weight management: Current evidence and future directions. Nutrients, 16(3), 456.
Vetrani, C., Barrea, L., Verde, L., Sarno, G., Docimo, A., de Alteriis, G., Savastano, S., Colao, A., & Muscogiuri, G. (2022). Evening chronotype is associated with severe NAFLD in obesity. International Journal of Obesity, 46(11), 1638–1643.
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002.
Frequently Asked Questions
Explore our frequently asked questions to learn more.